US FDA highlights role of Bayesian statistical methods in streamlining device trials
This article was originally published in RAJ Devices
Executive Summary
New guidance issued by the US Food and Drug Administration could result in less costly and more efficient patient studies1-3. The document provides recommendations on using Bayesian statistical methods for designing and analysing medical device clinical trials.